These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 23442798)

  • 41. PFTK1 regulates cell proliferation, migration and invasion in epithelial ovarian cancer.
    Zhang W; Liu R; Tang C; Xi Q; Lu S; Chen W; Zhu L; Cheng J; Chen Y; Wang W; Zhong J; Deng Y
    Int J Biol Macromol; 2016 Apr; 85():405-16. PubMed ID: 26772918
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway.
    Chen S; Chen X; Xiu YL; Sun KX; Zhao Y
    PLoS One; 2015; 10(5):e0125714. PubMed ID: 25933027
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sam68 is Overexpressed in Epithelial Ovarian Cancer and Promotes Tumor Cell Proliferation.
    Dong L; Che H; Li M; Li X
    Med Sci Monit; 2016 Sep; 22():3248-56. PubMed ID: 27623016
    [TBL] [Abstract][Full Text] [Related]  

  • 44. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
    Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
    Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
    [TBL] [Abstract][Full Text] [Related]  

  • 45. BRMS1L suppresses ovarian cancer metastasis via inhibition of the β-catenin-wnt pathway.
    Cao P; Zhao S; Sun Z; Jiang N; Shang Y; Wang Y; Gu J; Li S
    Exp Cell Res; 2018 Oct; 371(1):214-221. PubMed ID: 30118697
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Over-Expression of TBL1XR1 Indicates Poor Prognosis of Serous Epithelial Ovarian Cancer.
    Ma M; Yu N
    Tohoku J Exp Med; 2017 Mar; 241(3):239-247. PubMed ID: 28344213
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MicroRNA‑139 suppressed tumor cell proliferation, migration and invasion by directly targeting HDGF in epithelial ovarian cancer.
    Liu J; Jin S; Wang R
    Mol Med Rep; 2017 Sep; 16(3):3379-3386. PubMed ID: 28713954
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dickkopf-4 is frequently overexpressed in epithelial ovarian carcinoma and promotes tumor invasion.
    Wang S; Wei H; Zhang S
    BMC Cancer; 2017 Jun; 17(1):455. PubMed ID: 28666421
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Altered expression of different GalNAc‑transferases is associated with disease progression and poor prognosis in women with high-grade serous ovarian cancer.
    Sheta R; Bachvarova M; Plante M; Gregoire J; Renaud MC; Sebastianelli A; Popa I; Bachvarov D
    Int J Oncol; 2017 Dec; 51(6):1887-1897. PubMed ID: 29039611
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Formyl peptide receptor 2 expression predicts poor prognosis and promotes invasion and metastasis in epithelial ovarian cancer.
    Xie X; Yang M; Ding Y; Yu L; Chen J
    Oncol Rep; 2017 Dec; 38(6):3297-3308. PubMed ID: 29039544
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of Sp1 and survivin in epithelial ovarian cancer: Sp1 inhibitor and cisplatin, a novel combination for inhibiting epithelial ovarian cancer cell proliferation.
    Sankpal UT; Ingersoll SB; Ahmad S; Holloway RW; Bhat VB; Simecka JW; Daniel L; Kariali E; Vishwanatha JK; Basha R
    Tumour Biol; 2016 Oct; 37(10):14259-14269. PubMed ID: 27581819
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MiR-381 inhibits epithelial ovarian cancer malignancy via YY1 suppression.
    Xia B; Li H; Yang S; Liu T; Lou G
    Tumour Biol; 2016 Jul; 37(7):9157-67. PubMed ID: 26768613
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The involvement of RhoA and Wnt-5a in the tumorigenesis and progression of ovarian epithelial carcinoma.
    Chen S; Wang J; Gou WF; Xiu YL; Zheng HC; Zong ZH; Takano Y; Zhao Y
    Int J Mol Sci; 2013 Dec; 14(12):24187-99. PubMed ID: 24351810
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ligand-dependent EGFR activation induces the co-expression of IL-6 and PAI-1 via the NFkB pathway in advanced-stage epithelial ovarian cancer.
    Alberti C; Pinciroli P; Valeri B; Ferri R; Ditto A; Umezawa K; Sensi M; Canevari S; Tomassetti A
    Oncogene; 2012 Sep; 31(37):4139-49. PubMed ID: 22158046
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Malignant ascites enhances migratory and invasive properties of ovarian cancer cells with membrane bound IL-6R in vitro.
    Kim S; Gwak H; Kim HS; Kim B; Dhanasekaran DN; Song YS
    Oncotarget; 2016 Dec; 7(50):83148-83159. PubMed ID: 27825119
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CKS2 promotes tumor progression and metastasis and is an independent predictor of poor prognosis in epithelial ovarian cancer.
    Xu JH; Wang Y; Xu D
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3225-3234. PubMed ID: 31081074
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of stress-induced phosphoprotein1 (STIP1) is associated with tumor progression and poor prognosis in epithelial ovarian cancer.
    Cho H; Kim S; Shin HY; Chung EJ; Kitano H; Hyon Park J; Park L; Chung JY; Hewitt SM; Kim JH
    Genes Chromosomes Cancer; 2014 Apr; 53(4):277-88. PubMed ID: 24488757
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Collagen triple helix repeat containing 1 (CTHRC1) activates Integrin β3/FAK signaling and promotes metastasis in ovarian cancer.
    Guo B; Yan H; Li L; Yin K; Ji F; Zhang S
    J Ovarian Res; 2017 Oct; 10(1):69. PubMed ID: 29021002
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Downregulation of microRNA-630 inhibits cell proliferation and invasion and enhances chemosensitivity in human ovarian carcinoma.
    Zou YT; Gao JY; Wang HL; Wang Y; Wang H; Li PL
    Genet Mol Res; 2015 Jul; 14(3):8766-77. PubMed ID: 26345808
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High GMFG expression correlates with poor prognosis and promotes cell migration and invasion in epithelial ovarian cancer.
    Zuo P; Ma Y; Huang Y; Ye F; Wang P; Wang X; Zhou C; Lu W; Kong B; Xie X
    Gynecol Oncol; 2014 Mar; 132(3):745-51. PubMed ID: 24486602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.